DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹6,393 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹507,872 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹6,393 Cr |
| Mar2025 | ₹5,639 Cr |
| Mar2024 | ₹5,398 Cr |
| Mar2023 | ₹507,872 Cr |
| Mar2022 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,393 Cr | 13.37 | |
| Mar2025 | ₹5,639 Cr | 4.46 | |
| Mar2024 | ₹5,398 Cr | -98.94 | |
| Mar2023 | ₹507,872 Cr | 12,261.98 | |
| Mar2022 | ₹4,108 Cr | - | |
Compare Total Expenditure of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹230,454.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
| MANKIND PHARMA | ₹97,756.1 Cr | -0.6% | -5.2% | -4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.2% |
17.3% |
38.7% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses